Loading…
PerkinElmer has agreed to acquire Horizon Discovery Group for approximately $383 million, adding gene editing and gene modulation tools to its life sciences portfolio.
“PerkinElmer has agreed to acquire Horizon Discovery Group for approximately $383 million, in a deal intended to add gene editing and gene modulation tools to the buyer’s portfolio.”genengnews.com
Summarized from public sources; check the original articles before acting on it.